Total Payments
$11,262
2024 Payments
$3,161
Companies
27
Transactions
484
Medicare Patients
6,392
Medicare Billing
$524,598
Payment Breakdown by Category
Food & Beverage$10,892 (96.7%)
Education$369.97 (3.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,892 | 480 | 96.7% |
| Education | $369.97 | 4 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,705 | 104 | $0 (2024) |
| Amgen Inc. | $1,355 | 57 | $0 (2024) |
| Incyte Corporation | $822.11 | 32 | $0 (2024) |
| Janssen Biotech, Inc. | $778.41 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $761.31 | 43 | $0 (2024) |
| Lilly USA, LLC | $644.50 | 31 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $491.16 | 17 | $0 (2024) |
| PFIZER INC. | $455.16 | 19 | $0 (2024) |
| LEO Pharma Inc. | $452.44 | 22 | $0 (2024) |
| UCB, Inc. | $448.31 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,161 | 133 | ABBVIE INC. ($889.26) |
| 2023 | $3,093 | 116 | ABBVIE INC. ($702.55) |
| 2022 | $2,641 | 122 | ABBVIE INC. ($526.87) |
| 2021 | $2,368 | 113 | AbbVie Inc. ($586.55) |
All Payment Transactions
484 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.52 | General |
| Category: Immunology | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $34.51 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.92 | General |
| 11/20/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $1.45 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.21 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.24 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.10 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.54 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.06 | General |
| Category: Immunology | ||||||
| 10/17/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: DERMATOLOGY | ||||||
| 10/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $32.87 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $31.74 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,869 | 4,484 | $623,020 | $153,042 |
| 2022 | 13 | 1,692 | 4,111 | $606,067 | $157,783 |
| 2021 | 12 | 1,476 | 3,638 | $458,245 | $122,429 |
| 2020 | 12 | 1,355 | 2,800 | $393,749 | $91,344 |
Total Patients
6,392
Total Services
15,033
Medicare Billing
$524,598
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 375 | 475 | $137,597 | $35,823 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 303 | 413 | $82,600 | $24,859 | 30.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 204 | 274 | $87,561 | $22,061 | 25.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 97 | 177 | $83,190 | $21,210 | 25.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 292 | 438 | $100,627 | $17,697 | 17.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 276 | 2,305 | $46,035 | $11,307 | 24.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 94 | 108 | $31,860 | $7,531 | 23.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 67 | 67 | $19,430 | $4,731 | 24.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 76 | 97 | $11,640 | $3,781 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $11,000 | $1,697 | 15.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 13 | 31 | $4,805 | $1,058 | 22.0% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 11 | 14 | $2,660 | $663.32 | 24.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 12 | 15 | $3,744 | $589.47 | 15.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 24 | 45 | $270.00 | $35.58 | 13.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 433 | 636 | $184,440 | $54,695 | 29.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 224 | 326 | $104,200 | $26,608 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 237 | 322 | $64,400 | $18,150 | 28.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 262 | 413 | $94,990 | $17,849 | 18.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 67 | 136 | $63,920 | $17,104 | 26.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 242 | 2,003 | $40,060 | $9,945 | 24.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 60 | 60 | $17,400 | $4,088 | 23.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 47 | 49 | $14,708 | $3,661 | 24.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 65 | 77 | $9,240 | $2,796 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $4,840 | $1,373 | 28.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 14 | 31 | $4,805 | $873.72 | 18.2% |
About Megan Webb, PA-C
Megan Webb, PA-C is a Physician Assistant healthcare provider based in Brookline, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1679607774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Megan Webb, PA-C has received a total of $11,262 in payments from pharmaceutical and medical device companies, with $3,161 received in 2024. These payments were reported across 484 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($10,892).
As a Medicare-enrolled provider, Webb has provided services to 6,392 Medicare beneficiaries, totaling 15,033 services with total Medicare billing of $524,598. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Brookline, MA
- Active Since 03/14/2007
- Last Updated 03/10/2008
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1679607774
Products in Payments
- Otezla (Drug) $1,355
- SKYRIZI (Biological) $1,321
- RINVOQ (Biological) $1,058
- OPZELURA (Drug) $722.12
- DUPIXENT (Biological) $622.41
- TALTZ (Drug) $528.44
- TREMFYA (Drug) $499.06
- COSENTYX (Biological) $489.70
- EUCRISA (Drug) $455.16
- Sotyktu (Drug) $426.75
- Cimzia (Drug) $402.77
- ADBRY (Biological) $307.98
- Avar (Drug) $290.72
- REMICADE (Biological) $279.35
- HUMIRA (Biological) $255.20
- VTAMA (Drug) $222.53
- SPEVIGO (Drug) $206.07
- ENSTILAR (Drug) $144.46
- Winlevi (Drug) $131.26
- COSENTYX (Drug) $107.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Brookline
Ms. Hanna Sutton, Pa-C, PA-C
Physician Assistant — Payments: $3,634
Physician Assistant $3,634
Mr. Jeffrey Lucak, Pa-C, PA-C
Physician Assistant — Payments: $1,945
Physician Assistant $1,945
Blakely Plaster, Pa-C, PA-C
Physician Assistant — Payments: $1,887
Physician Assistant $1,887
Tamra Adams, Pa-C, PA-C
Physician Assistant — Payments: $581.61
Physician Assistant $581.61
Nelya Christiansen, Pa-C, PA-C
Physician Assistant — Payments: $529.88
Physician Assistant $529.88
Ms. Kayla Morse, Pa-C, PA-C
Physician Assistant — Payments: $323.95
Physician Assistant $323.95